what glp 1 is serena williams taking Why Went Public About Losing Weight With Zepbound Serena Williams weight loss drug:

Retatrutide-treated groups showed WOMAC pain reductions of up to 4.5 points, corresponding to roughly a 75.8 percent reduction in the pain score relative to baseline

A key driver of this process is insulin resistance, which affects both hepatic and peripheral tissues, creating a metabolic environment that simultaneously promotes hyperglycemia and hepatic steatosis through selective pathway activation

Additionally, there were no substantial differences observed in the gastric emptying time of liquids, and no significant variation between the gastric emptying times associated with long-acting and short-acting GLP-1 medications

People who have severe gastrointestinal conditions like inflammatory bowel disease (IBD) or gastroparesis should not go on GLP-1s, and neither should people with a personal or family history of multiple endocrine neoplasia 2A, multiple endocrine neoplasia 2B, medullary thyroid cancer, or pancreatitis

While it doesnt accept insurance, the program is FSA/HSA eligible

A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans